lunes, 31 de julio de 2023

FDA approves dostarlimab-gxly with chemotherapy for endometrial cancer

https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-dostarlimab-gxly-chemotherapy-endometrial-cancer?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario